|
|
|
Volumn 16, Issue 4, 2002, Pages
|
|
Irinotecan therapy for small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CISPLATIN;
DNA TOPOISOMERASE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
ETOPOSIDE;
IRINOTECAN;
CLINICAL TRIAL;
DRUG ANTAGONISM;
HUMAN;
JAPAN;
LUNG TUMOR;
MORTALITY;
REVIEW;
SMALL CELL CARCINOMA;
SURVIVAL;
UNITED STATES;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARCINOMA, SMALL CELL;
CISPLATIN;
CLINICAL TRIALS;
DNA TOPOISOMERASES, TYPE I;
ENZYME INHIBITORS;
ETOPOSIDE;
HUMANS;
JAPAN;
LUNG NEOPLASMS;
SURVIVAL ANALYSIS;
UNITED STATES;
|
|
EID: 0036545482
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (14)
|
|
References (92)
|
